Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy

NCT05747794 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

849

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Carcinoma

Interventions

BIOLOGICAL: eftilagimod alpha
DRUG: Paclitaxel
OTHER: placebo

Sponsor

Immutep S.A.S.